Literature DB >> 22050852

Immune and neuroimmune alterations in mood disorders and schizophrenia.

Roosmarijn C Drexhage1, Karin Weigelt, Nico van Beveren, Dan Cohen, Marjan A Versnel, Willem A Nolen, Hemmo A Drexhage.   

Abstract

A large number of publications over the past 20 years have indicated that immune system function is altered in schizophrenia and mood disorder patients. This chapter reviews the evidence, which suggests that a proinflammatory state of the cytokine network induces psychopathologic symptoms and may be involved in the pathogenesis and pathophysiology of these major mental illnesses. The authors also present recent data, which relates immune activation to present theories on the influence of activated immune cells in altering brain function. They also focus on the role of the environment in immune activation and on the role of the microbiome and gut flora. Increased understanding of such factors could help in the development of novel treatment strategies and improved clinical management of mental disorders. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22050852     DOI: 10.1016/B978-0-12-387718-5.00007-9

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  27 in total

1.  Innate immunity in the postmortem brain of depressed and suicide subjects: Role of Toll-like receptors.

Authors:  Ghanshyam N Pandey; Hooriyah S Rizavi; Runa Bhaumik; Xinguo Ren
Journal:  Brain Behav Immun       Date:  2018-09-25       Impact factor: 7.217

2.  Association between schizophrenia and an autoimmune bullous skin disease-pemphigus: a population-based large-scale study.

Authors:  K Kridin; S Zelber-Sagi; D Comaneshter; A D Cohen
Journal:  Epidemiol Psychiatr Sci       Date:  2017-09-25       Impact factor: 6.892

Review 3.  Biological indicators of suicide risk in youth with mood disorders: what do we know so far?

Authors:  Ute Lewitzka; Sarah Doucette; Florian Seemüller; Paul Grof; Anne C Duffy
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

4.  Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder.

Authors:  Emily G Severance; Kristin L Gressitt; Shuojia Yang; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Armin Alaedini; Faith B Dickerson; Robert H Yolken
Journal:  Bipolar Disord       Date:  2013-12-06       Impact factor: 6.744

5.  Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Cassie R Stallings; Andrea E Origoni; Sunil Khushalani; F Markus Leweke; Faith B Dickerson; Robert H Yolken
Journal:  Schizophr Res       Date:  2013-06-06       Impact factor: 4.939

6.  Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls.

Authors:  Suzanne Medema; Roel J T Mocking; Maarten W J Koeter; Frédéric M Vaz; Carin Meijer; Lieuwe de Haan; Nico J M van Beveren; René Kahn; Lieuwe de Haan; Jim van Os; Durk Wiersma; Richard Bruggeman; Wiepke Cahn; Carin Meijer; Inez Myin-Germeys
Journal:  Schizophr Bull       Date:  2015-09-18       Impact factor: 9.306

Review 7.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

8.  Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update.

Authors:  Iris E Sommer; Roos van Westrhenen; Marieke J H Begemann; Lot D de Witte; Stefan Leucht; René S Kahn
Journal:  Schizophr Bull       Date:  2013-10-08       Impact factor: 9.306

Review 9.  Towards a 'systems'-level understanding of the nervous system and its disorders.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Trends Neurosci       Date:  2013-08-27       Impact factor: 13.837

10.  IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Armin Alaedini; Cathrin Rohleder; Frank Enning; J Malte Bumb; Juliane K Müller; Emanuel Schwarz; Robert H Yolken; F Markus Leweke
Journal:  Brain Behav Immun       Date:  2014-09-20       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.